Overexpression of pRB in human pancreatic carcinoma cells: Function in chemotherapy-induced apoptosis

Journal of the National Cancer Institute

Volumn 94, Issue 2, 2002, Pages 129-142

  Plath, Thomas ^a   Peters, Michael ^a   Detjen, Katharina ^a   Welzel, Martina ^a   Von Marschall, Zofia ^a   Radke, Cornelia ^a   Wiedenmann, Bertram ^a   Rosewicz, Stefan ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; GEMCITABINE; PROTEIN P16; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARCINOMA CELL; CELL PROTECTION; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE LOSS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; NORTHERN BLOTTING; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSACTIVATION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILD TYPE;

EID: 0037116623     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.2.129     Document Type: Article

References (61)

1. Pancreatic cancer
2. Pancreatic carcinoma
3. No standard treatment is available for advanced pancreatic cancer
4. Recent discoveries in cancer genetics of exocrine pancreatic neoplasia
5. Advances from genetic clues in pancreatic cancer
6. Tumor-suppressive pathways in pancreatic carcinoma
7. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes
8. G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: Phenotypes reversed by a tumorigenic mutation
9. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity
10. p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells
11. Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells
12. Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene
13. Retinoblastoma: The disease, gene and protein provide critical leads to understand cancer
14. Cell-cycle inhibitors: Three families united by a common cause
15. The Pezcoller lecture: Cancer cell cycles revisited
16. DP and E2F proteins: Components of a heterodimeric transcription factor implicated in cell cycle control
17. Transcriptional regulation during the mammalian cell cycle
18. Principles of CDK regulation
19. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
20. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRB
21. The tumor suppressor protein p16INK4a
22. Expression of p16 induces transcriptional downregulation of the RB gene
23. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death
24. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression
25. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance
26. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
27. Requirement for a functional Rb-1 gene in murine development
28. Inhibition of apoptosis by the retinoblastoma gene product
29. Retinoblastoma protein inhibits IFN-gamma induced apoptosis
30. Induction of apoptosis in HeLa cells by trans-activation-deficient p53
31. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity
32. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas
33. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
34. Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study
35. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
36. pRb and p107 regulate E2F activity during lens fiber cell differentiation
37. Cell-cycle regulation of human B-myb transcription
38. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes
39. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells
40. Induction of apoptosis by cancer chemotherapy
41. Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy
42. Chronic pancreatitis and other risk factors for pancreatic cancer
43. Expression of the retinoblastoma protein is regulated in normal human tissues
44. Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer
45. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis
46. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas
47. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines
48. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells
49. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts
50. Interferon-gamma modulates retinoblastoma gene mRNA in monocytoid cells
51. The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product
52. Hammerhead ribozyme specifically inhibits mutant K-ras mRNA of human pancreatic cancer cells
53. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells
54. The paradox of E2F1: Oncogene and tumor suppressor gene
55. Apoptosis and the dilemma of cancer chemotherapy
56. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
57. The E2F transcription factors: Key regulators of cell proliferation
58. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction
59. Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses
60. Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development
61. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells